Maharaja & Speedex India opened for subscription on 10 Sept and closes on 15 Sept 2026. GMP is ₹30 (about 16.1% over the cap price), and the issue is 0.27x subscribed so far.
Maharaja & Speedex India IPO Subscription Status
| Category | Subscribed (times) | Bids received |
|---|---|---|
| QIB | 0.1x | ₹0.81 cr |
| NII (HNI) | 0.86x | ₹7.10 cr |
| Retail | 0.56x | ₹7.98 cr |
| Total | 0.52x | ₹15.89 cr |
Updated through the bidding window; final numbers settle after the issue closes.
Maharaja & Speedex India IPO Day-wise GMP
Latest grey market premium: ₹45 (about 24.2% over the cap price).
| Date | GMP | Est. gain |
|---|---|---|
| 8 September | ₹14 | 7.53% |
GMP is unofficial and changes through the day; it is not endorsed by SEBI or the exchanges and should not be the only basis for a decision.
Should You Apply to Maharaja & Speedex India IPO?
As things stand, the grey market premium points to a listing near ₹216 (about 16.1%), the issue is subscribed 0.27x overall so far, retail is at 0.22x. In the company's favour: Broad product portfolio of stainless-steel kitchenware and household items. The main risk to weigh: Reliance on a limited number of suppliers for stainless-steel raw materials. Judge the price against the company's earnings and your holding period, not the GMP alone.
How to Apply for Maharaja & Speedex India IPO
- Log in to your broker's IPO section and select Maharaja & Speedex India.
- Bid at the cut-off price for the best chance of allotment (retail).
- Enter the number of lots (minimum 600 shares) and submit your UPI ID.
- Approve the mandate request in your UPI app before the cut-off time to block the funds.
Quick facts: Price band ₹177 – ₹186 · Lot 600 shares (~₹2,23,200) · Bidding 10 Sept – 15 Sept · Listing 18 Sept on BSE SME · Registrar Maashitla Securities Pvt. Ltd.
More on Maharaja & Speedex India IPO
- Maharaja & Speedex India IPO — live GMP, subscription & allotment status
- Maharaja & Speedex India IPO listing gain calculator
- All SME IPOs
- Full IPO list with GMP
This article is for information only and is not investment advice. Read the RHP and consider your own risk profile before investing.
Loading comments...